Director, Medical Affairs: Hematology Strategy

Regeneron Pharmaceuticals, Inc.; Sleepy Hollow (WY); On-site; USD 205,000 - 342,000; Full time

Job summary

Regeneron Pharmaceuticals in Sleepy Hollow, NY is seeking a Director of Medical Affairs, Hematology to shape medical strategy and lead evidence generation while collaborating with Medical Affairs, R&D, Commercial and external practitioners.

You will lead the cross-functional Medical Product Team in a matrix environment, oversee Phase 3B/4 studies, guide publications and presentations, and engage the scientific community to advance disease management.

Qualifications

• MD/PhD/PharmD required or equivalent.
• 5+ years in biotech/pharmaceutical Medical Affairs.
• Experience in Hematology/Oncology clinical research or drug development.

Responsibilities

• Define medical strategy, set annual goals, and ensure compliant execution of Medical Affairs activities.
• Serve as a key scientific and medical resource with deep knowledge of the Hematology disease area.
• Lead the cross-functional Medical Product Team (MPT) in a matrix environment.
• Shape evidence generation strategy and oversee Phase 3B/4 studies (interventional and observational).
• Guide publications and presentations in partnership with the Publication Manager.
• Engage the external scientific community to advance disease management standards of care.
• Develop medical content for congresses, symposia, and advisory boards; lead these activities.
• Present scientific and medical information to diverse audiences, including physicians, pharmacists, and agency partners.

Skills

Medical Affairs leadership

Hematology/Oncology knowledge

Scientific communication

Cross-functional collaboration

Education

MD/PhD/PharmD

Job description

Regeneron Pharmaceuticals in Sleepy Hollow, NY is seeking a Director of Medical Affairs, Hematology to shape medical strategy and lead evidence generation while collaborating with Medical Affairs, R&D, Commercial and external practitioners.

You will lead the cross-functional Medical Product Team in a matrix environment, oversee Phase 3B/4 studies, guide publications and presentations, and engage the scientific community to advance disease management.